Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome

Table 2

	MS patients withoutDM	MS patients withDM	MS patients with low TG/HDL index	MS patients with high TG/HDL index
Waist circumference (cm)	102.8±8.8	114.4±11.7^§	106.7±11.16	106.8±11.46
Body mass index (Kg/m^2)	31.5±4.2	33.2±5.0^∗	32.45±4.55	31.94±4.55
Systolic blood pressure (mmHg)	130.0±13.3	136.0±20.5	133.2±18.8	131.1±13.7
Diastolic blood pressure (mmHg)	82.2±8.9	79.6±11.4	80.5±10.9	81.94±8.9
Fasting glucose (mg/dL)	92.2±10.3	147.5±54.2^§	114.5±39.7	114.2±48.7
Total cholesterol (mg/dL)	228.0±48.3	193.1±53.1^§	201.2±40.8	226.6±60.6^†
HDL-cholesterol (mg/dL)	39.7±9.3	41.4±12.8	46.9±9.3	33.9±8.1^‡
LDL-cholesterol (mg/dL)	147.9±45.8	112.8±39.7^§	123.5±37.5	143.0±58.7
Triglycerides (mg/dL)	231.0±145.9	204.2±150.9	137.4±42.6	302.9±168.4^‡
TG/HDL index	6.739±6.190	5.900±5.832	3.00±0.95	9.80±7.00^‡

Means ± S.D. of the anthropometric profile, blood pressure values, and metabolic pattern in MS patients subdivided, respectively, into nondiabetics and diabetics and into patients with low and high TG/HDL index.
* 𝑃<0.05; ^§𝑃<0.001 versus MS patients without DM (Student’s 𝑡-test).
^†𝑃<0.05; ^‡𝑃<0.001 versus MS patients with low TG/HDL index (Student’s 𝑡-test).
MS: metabolic syndrome.
DM: diabetes mellitus.